Solutions
About Us
Insights
Careers

Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis. Ren, S., Singh, J., Gsteiger, S., Cogley, C., Reed, B., Abrams, K. R., Dawoud, D., Owen, R. K., Tappenden, P., Quinn, T. J., & Bujkiewicz, S. (2026). . Journal of comparative effectiveness research, 15(1), e250095.

Simplifying fractional polynomials in Bayesian network meta-analysis via variable powers. Verhoek, A., Ouwens, M. J., Heeg, B., Jansman, F. G., & Postma, M. J. (2026). . Journal of comparative effectiveness research, 15(1), e250126.

Webinar – Boosting Phase III Probability of Success with Informed Priors from Phase II Data

SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols. Ursino M, Villacampa G, Rekowski J, Dimairo M, Solovyeva O, Ashby D, Berlin J, Boix O, Calvert M, Chan AW, Coschi CH, Evans TRJ, Garrett-Mayer E, Golub RM, Guo C, Hayward KS, Hopewell S, Isaacs JD, Ivy SP, Jaki T, Kholmanskikh O, Kightley A, Lee S, Liu R, Mander A, Marshall LV, Matcham J, Patel D, Peck R, Rantell KR, Richards DP, Rouhifard M, Seymour L, Tanaka Y, Weir CJ, de Bono J, Yap C. EClinicalMedicine. 2025

CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials. Rekowski J, Guo C, Solovyeva O, Dimairo M, Rouhifard M, Patel D, Alger E, Ashby D, Berlin J, Boix O, Calvert M, Chan AW, Coschi CH, de Bono J, Evans TRJ, Garrett-Mayer E, Golub RM, Hayward KS, Hopewell S, Isaacs JD, Ivy SP, Jaki T, Kholmanskikh O, Kightley A, Lee S, Liu R, Maia I, Mander A, Marshall LV, Matcham J, Peck R, Rantell KR, Richards DP, Seymour L, Tanaka Y, Ursino M, Weir CJ, Yap C. EClinicalMedicine. 2025

Testing One Primary and Two Secondary Endpoints in a Two-Stage Group Sequential Trial With Extensions. Tamhane AC, Xi D, Mehta CR, Romanenko A, Gou J. Stat Med. 202

History, clinical presentation, therapy, and patient reported outcomes of mucosal lichen planus: a cross-sectional study. Cramer N, Kromer D, Bootsveld JM, Sennhenn-Kirchner S, Gerdes S, Sondermann W, Assaf K, Goebeler M, Wilsmann-Theis D, Günther C, Kromer C, Mössner R. J Dtsch Dermatol Ges. 2025

Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Zamulko O, Karivedu V, Riaz MK, Monroe I, Romano A, Mulanda R, Kurtzweil N, Forsythe A, Allen CL, Harun N, Pan J, Rai S, El-Gamal D, Wise-Draper TM. Cancer Research Communications. 2025

A Comparison of Two Methods for Adaptive Multi-Arm Two-Stage Design. Mehta C, Kappler M. Statistics in Medicine. 2025

White Paper – Clinical Trial SAS Programming Needs a Makeover: Agile Leads the Way